Whitehawk Therapeutics (WHWK) Short term Debt (2020 - 2021)
Whitehawk Therapeutics (WHWK) reported Short term Debt of $258000.0 for Q4 2021, down 98.2% year-over-year from $14.3 million in Q4 2020, and up 1072.73% quarter-over-quarter from $22000.0 in Q3 2021.
Whitehawk Therapeutics (WHWK) Short term Debt (2020 - 2021) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Short term Debt data on file, last reported at $258000.0 in Q4 2021.
- Short term Debt for Q4 2021 came in at $258000.0, down 98.2% year-over-year; the trailing twelve-month figure through Dec 2021 was $258000.0 (down 98.2% YoY), and the FY2021 annual result was $258000.0, down 98.2% from the prior year.
- Short term Debt grew to $258000.0 in Q4 2021 per WHWK's latest filing, from $22000.0 in the prior quarter.
- Over five years, Short term Debt peaked at $14.3 million in Q4 2020 and troughed at $22000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 258,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Dec 31, 2020 | 14.31 Mn |